Cartilage and extracellular matrix turnover

Cartilage and extracellular matrix (ECM) turnover is a dynamic physiological process characterized by the balanced synthesis and degradation of the cartilage matrix, primarily composed of type II collagen and aggrecan (Goldring & Goldring, 2007). This process is regulated by chondrocytes, which respond to mechanical and chemical signals by producing anabolic factors like TGF-beta and catabolic enzymes such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) (Nagase & Visse, 2003). In healthy joints, this turnover maintains the structural integrity and mechanical properties of the tissue. However, in degenerative diseases like osteoarthritis, an imbalance occurs where catabolic activity outweighs anabolic repair, leading to progressive matrix depletion and joint failure (Malemud, 2006). Therapeutic interventions targeting this process include MMP inhibitors, aggrecanase inhibitors, and growth factor mimetics designed to restore matrix homeostasis (Wieland et al., 2005). Monitoring this turnover is often achieved through biochemical biomarkers such as C-terminal telopeptide of type II collagen (CTX-II) and cartilage oligomeric matrix protein (COMP) (Lohmander et al., 2003).

Other names

Extracellular matrix remodelingCartilage metabolismChondrocyte-mediated matrix turnoverECM homeostasis

Modulation of the balance between anabolic synthesis and catabolic degradation of cartilage components through inhibition of proteases (MMPs, ADAMTS) or activation of growth factor signaling.